Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122862 · ClinicalTrials.gov registry record · Phase 2
Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth
A Phase 2 study of Healthy Subjects, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT01122862 is a Phase 2 study of Healthy Subjects that has completed, run by GlaxoSmithKline. The registered enrollment target is 23 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01122862, a Phase 2 study of Healthy Subjects, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth
Conditions Studied
Interventions
- DRUG 0.12% chlorhexidine mouthrinse
- OTHER Cosmetic mouthrinse
- OTHER Sterile water
Study Locations (1)
Indiana
- GSK Investigational Site - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122862
The ClinicalTrials.gov registry entry for NCT01122862 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (82% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 3 interventions - of which 0.12% chlorhexidine mouthrinse is the first listed.
NCT01122862 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT01122862 about?
NCT01122862 is a clinical study titled "Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth". A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth
What is the current status of trial NCT01122862?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2010-04. Estimated completion is 2010-05.
What conditions does trial NCT01122862 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT01122862?
The interventions under investigation include: 0.12% chlorhexidine mouthrinse (DRUG), Cosmetic mouthrinse (OTHER), Sterile water (OTHER).
Who is sponsoring clinical trial NCT01122862?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01122862 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
RECRUITING · Phase 2
-
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.
COMPLETED · Phase 2
-
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
RECRUITING
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
Radiocaine Safety Study In Healthy Human Subjects
RECRUITING · Early Phase 1
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.